Organisation paid for research Program year 2022 Source: CMS Open Payments

Apex Cardiology

Neither a doctor nor a teaching hospital

Research payments

$6,519

4 payments

Through program year 2022, Apex Cardiology is reported as receiving $6,519 in research payments, across 4 payments.

By program year

2 rows

Year	Kind	Amount	Payments
2022	Research	$450	1
2019	Research	$6,068	3

Breakdown

Who paid Research payments · program years 2019–2022

Merck Sharp & Dohme Corporation $3,820 3 payments
E.R. Squibb & Sons, L.L.C. $2,699 1 payment

Studies the money was for Research payments · program years 2019–2022

A randomized parallel-group, placebo-controlled, double-blind, event-driven, multi-center pivotal phase III clinical outcome trial of efficacy and safety of the oral sGC stimulator Vericiguat in subjects with heart failure and reduced ejection fraction HFrEF - VerICiguaT glObal study in subjects with heart failure and Reduced ejectIon frAction VICTORIA $3,820 3 payments
An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients with Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention $2,699 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.